Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 22Vitamin D Deficiency 20Prostatic Neoplasms 17Polycystic Ovary Syndrome 10Neoplasms 9Colonic Neoplasms 8Rectal Neoplasms 6Colorectal Neoplasms 6Osteoporosis 5Myelodysplastic Syndromes 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Cardiovascular Diseases 4Warts 3Ovarian Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia 3Brain Neoplasms 3Adenomatous Polyps 3Pathologic Processes 2Pain 2Obesity 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Musculoskeletal Diseases 2Melanoma 2Male Urogenital Diseases 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

teriflunomide 1Vitamin D 1Natalizumab 1Interferon beta-1b 1Fingolimod Hydrochloride 1Dimethyl Fumarate 1Cholecalciferol 1Calcifediol 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Sclerosis, Relapsing-Remitting × Cholecalciferol × Clear all
NCT05340985 2022-04-22

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Tehran University of Medical Sciences

Phase 4 Unknown
54 enrolled
LymphoidOther hematologic neoplasm

Multiple Sclerosis, Relapsing-Remitting, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡